Effectiveness and safety of dual anti-platelet therapy after coronary artery bypass grafting: A meta-analysis

Chinese Journal of Evidence-Based Medicine

Volumn 14, Issue 8, 2014, Pages 958-965

  Jun Hong, Li ^a   Aikeremu, ^a   MuLa Ti, ^a   Ming Ming, Zhang ^a   Yilihamu, ^a   Aikebaier, ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Aspirin; Clopidogrel; Coronary artery bypass grafting (CABG); Dual anti platelet therapy; Meta analysis; Randomized controlled trial

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PLACEBO;

ARTERY GRAFT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OCCLUSION; DATA EXTRACTION; DRUG EFFICACY; DRUG SAFETY; ELECTRONIC MEDICAL RECORD; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; QUALITY CONTROL; RADIAL ARTERY GRAFT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAPHENOUS VEIN GRAFT; SYSTEMATIC REVIEW (TOPIC);

EID: 84908159334     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: 10.7507/1672-2531.20140159     Document Type: Review

References (20)

1. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg, 2012, 143(1): 4-34.
2. Stein PD, Schunemann HJ, Dalen JE, et al. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): 600S-608S.
3. Gurbuz AT, Zia AA, Vuran AC, et al. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardiothorac Surg, 2006, 29(2): 190-195.
4. Kulik A, Le May M, Wells GA, et al. The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidgorel and aspirin versus aspirin alone after coronary bypass surgery. Curr Control Trials Cardiovasc Med, 2005, 11(6): 15.
5. Patel JH, Stoner JA, Owora A, et al. Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients. Am J Cardiol, 2009, 103(12): 1687-1693.
6. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0). [cited 2012 Jan 5]. Available at: http:// www.cochrane-handbook.org.
7. Mujanovic E, Nurkic M, Caluk J, et al. The effect of combined clopidogrel and aspirin therapy after off-pump coronary surgery: a pilot study. Innovations (Phila), 2009, 4(5): 265-268.
8. Sun JC, Teoh KH, Lamy A, et al. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting study. Am Heart J, 2010, 160(6): 1178-1184.
9. Kulik A, Le May MR, Voisine P, et al. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. Circulation, 2010, 122(25): 2680-2687.
10. Mannacio VA, Di Tommaso L, Antignano A, et al. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of coronary artery bypass occlusion after off-pump procedures) randomized study. Heart, 2012, 98(23): 1710-1715.
11. Bhatt DL. Aspirin resistance: more than just a laboratory curiosity. J Am Coll Cardiol, 2004, 43(6): 1127-1129.
12. Bednar F, Osmancik P, Hlavicka J, et al. Aspirin is insufficient in inhibition of platelet aggregation and thromboxane formation early after coronary artery bypass surgery. J Thromb Thrombolysis, 2009, 27(4): 394-399.
13. Krasopoulos G, Brister SJ, Beattie WS, et al. Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and metaanalysis. BMJ, 2008, 336(1): 195-198.
14. Bednar F, Osmancik P, Hlavicka J, et al. Aspirin is insufficient in inhibition of platelet aggregation and thromboxane formation early after coronary artery bypass surgery. J Thromb Thrombolysis, 2009, 27(4): 394-399.
15. Halkos ME, Cooper WA, Petersen R, et al. Early administration of clopidogrel is safe after off-pump coronary artery bypass surgery. Ann Thorac Surg, 2006, 81(3): 815-819.
16. Goldman S, Zadina K, Moritz T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol, 2004, 44(11): 2149-2156.
17. Sabik JF, Lytle BW, Blackstone EH, et al. Comparison of Saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg, 2005, 79(2): 544-551.
18. Kim DH, Daskalakis C, Silvestry SC, et al. Aspirin and clopidogrel use in the early postoperative period following on-pump and offpump coronary artery bypass grafting. J Thorac Cardiovasc Surg, 2009, 138(6): 1377-1384.
19. Sanon S, Lee VV, Elayda M, et al. Use of aspirin versus clopidogrel plus aspirin after coronary artery bypass graft surgery. Clinical and Applied Thrombosis/Hemostasis, 2009, 15(5): 540-544.
20. Gasparovic H, Petricevic M, Kopjar T, et al. Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial. Trials, 2012, 13(1): 148.